COMPANY

Matinas Biopharma

Keywords: small molecule siRNA

Profile checked Oct 10, 2026

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

2025-02-19 Raise Private raise (SEC Form D): $1.6M sold of $3.3M offered; issuer “Matinas BioPharma Holdings, Inc.”. Verified from the SEC filing. SEC filing ↗